Table 2.
Details |
Meningioma Cases |
|||||||
---|---|---|---|---|---|---|---|---|
M10 | M14 | M15 | M16 | M21 | M29 | M37 | ||
Clinico-pathological details |
Age |
79 |
48 |
59 |
32 |
51 |
44 |
49 |
Gender |
Ml |
Fl |
Fl |
Fl |
Fl |
Fl |
Fl |
|
Grade |
I |
I |
I |
I |
I |
II |
I |
|
Variant/sub-type |
Mg |
T |
Mg |
T |
Fb |
At |
T |
|
Tumor location |
RSW |
LPP |
PS |
FM |
LP |
RF |
LO |
|
Recurrent case |
– |
– |
– |
– |
– |
– |
– |
|
Details of KIT-IHC analyses |
% positivitya |
4 |
2 |
2-4 |
1 |
4 |
3 |
1 |
Staining intensityb |
W |
Md |
W-Md |
W |
S |
S |
W |
|
Stain localizationc |
C |
C |
C |
C |
C |
C |
C |
|
Staining patternc | D,G | F,G | H,G | H,G | D | D | F,G |
(Clinical data: Ml, Male; Fl, Female. Ag, Angiomatous; At, Atypical; Ap, Anaplastic; Fb, Fibroblastic; Mg, Meningothelial; T, Transitional; FM, Foramen magnum; LO, Left occipital; LP, Left Parietal; LPP, Left parietal parasaggital; PS, Planum sphenoidale; RF, Right frontal; RSW, Right sphenoid wing.
Experimental data:a 0 = 0%, 1 + = 1–10%, 2 + = 11–50%, 3 + = 51–75%, 4 + = ≥ 75.
b W, Weak (+); Md, Moderate (++); S, Strong (+++).
c C, Cytoplasmic; D, Diffuse; F, Focal; G, Granular; H, Homogeneous.